Dihydergot plus

used in therapy of orthostatic disturbance & hypotension; contains above two cpds

Also Known As:

Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'alpha,10alpha)-, monomethanesulfonate (salt), mixt. with (R)-alpha-((ethylmethylamino)methyl)-3-hydroxybenzenemethanol

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Hypotension (Low Blood Pressure) 01/01/1982 - "[Dihydergot plus - 12-hour action in orthostatic disturbance and hypotension]." 10/23/1980 - "42 patients aged 75 /+- 12,5 years with orthostatic dysregulation and partly with hypotension were treated with the new combination of 20 mg etilefrine and 2 mg dihydroergotamine (Dihydergot plus) t.i.d. "
2.	Dizziness (Lightheadedness) 02/26/1982 - "Under acute conditions (15 healthy individuals; medication: placebo 0.25 Dihydergot i.v., 15 mg etilefrine p.o., 0.25 mg Dihydergot plus 15 mg etilefrine p.o.) superiority of the combination could be demonstrated concerning tonisation of the capacitance vessels and improvement of circulatory regulation during orthostasis, as indicated by less pronounced increase in heart rate. "

Related Drugs and Biologics

1.	Etilefrine (Thomasin)
2.	Dihydroergotamine (Agit)